Faculty: Shikha Wadhwani, MD

Faculty: Dana Rizk, MD

For the second episode of the KDIGO IgA Nephropathy (IgAN) podcast series, Dr. Dana Rizk and Dr. Shikha Wadhwani discuss the IgAN treatment revolution. The conversation explores how a deeper understanding of the disease's pathophysiology has led to new therapeutic options, moving beyond traditional supportive care.

Key topics include:

• The shift in IgAN treatment since the KDIGO 2021 guidelines
  
• The four-hit hypothesis of IgAN, and how new therapies are being developed to target each step of the disease's pathogenesis
  
• Factors for clinicians to consider when choosing new treatments
  
• The evolving role of traditional therapies alongside newer agents

This episode was supported by Travere